earnings

Merck posts strong first-quarter profit, but revenue light
Yahoo/AP
Tue, 05/1/18 - 09:29 pm
Merck
earnings
GSK's Shingrix blows past sales projections, pushing 2018 estimates to $600M
Fierce Pharma
Mon, 04/30/18 - 07:36 pm
GSK
vaccines
earnings
Shingrix
shingles
AbbVie's First Quarter: Trying to Replace Humira Sales
Yahoo/Motley Fool
Sun, 04/29/18 - 03:40 pm
AbbVie
earnings
Humira
What to Expect With Gilead Sciences Inc.'s Q1 Earnings Results
Motley Fool
Sun, 04/29/18 - 12:11 pm
Gilead Sciences
earnings
What to Expect with Pfizer's Q1 Results
Motley Fool
Sun, 04/29/18 - 12:09 pm
Pfizer
earnings
Allergan: Q1 Results Could Convince Bulls Growth Is Dead
Seeking Alpha
Sat, 04/28/18 - 11:49 am
Allergan
earnings
BioMarin Cruises While It Waits on Seventh Approval
Motley Fool
Fri, 04/27/18 - 08:15 pm
Biomarin
pegvaliase
FDA
PKU
earnings
Why Seattle Genetics Jumped Higher Today
Motley Fool
Fri, 04/27/18 - 08:06 pm
Seattle Genetics
earnings
Adcetris
Stryker Q1 beats The Street
Mass Device
Fri, 04/27/18 - 11:34 am
Stryker
earnings
devices
Sanofi Stumbles as Key Medicines' Sales Spark Growth Concerns
Bloomberg
Fri, 04/27/18 - 10:11 am
Sanofi
earnings
Biogen’s Spinraza Sales Slow as AveXis and Novartis Pursue SMA Gene Therapy
Xtalks
Fri, 04/27/18 - 10:03 am
Biogen
earnings
Spinraza
spinal muscular atrophy
Hey, Takeda shareholders: Shire's Q1 may ease some buyout worries, analysts say
Fierce Pharma
Thu, 04/26/18 - 09:53 pm
Takeda
Shire
M&A
earnings
Vertex Pharma Tops Quarterly Views On Strong Cystic Fibrosis Drug Sales
Investors Business Daily
Thu, 04/26/18 - 07:23 pm
Vertex Pharmaceuticals
earnings
Ocrevus fuels fast start to year for Roche
Biopharma Dive
Thu, 04/26/18 - 07:21 pm
Roche
earnings
Ocrevus
Bristol-Myers profit tops Street view, raises 2018 forecast
Reuters
Thu, 04/26/18 - 10:10 am
Bristol-Myers Squibb
earnings
AbbVie shares rise 3% on Q1 profit, revenue beats and $7.5 billion share buyback
Marketwatch
Thu, 04/26/18 - 10:06 am
AbbVie
earnings
Amgen focuses on migraine launch as growth remains slow
Biopharma Dive
Wed, 04/25/18 - 10:54 pm
Amgen
earnings
Repatha
Kyprolis
Prolia
Xgeva
Look at our new launches, GSK urges, as its respiratory woes steal the limelight
Fierce Pharma
Wed, 04/25/18 - 10:38 pm
GSK
earnings
HIV
Shingrix
Immunotherapies, biosimilars to dominate next week of earnings
Biopharma Dive
Tue, 04/24/18 - 10:50 pm
AbbVie
AstraZeneca
Bristol-Myers Squibb
Celgene
Roche
Vertex Pharmaceuticals
Sanofi
earnings
Lilly’s strong Q1 cushions the blow of FDA thumbs-down on high-dose baricitinib
Fierce Pharma
Tue, 04/24/18 - 10:44 pm
Eli Lilly
earnings
baricitinib

Pages